Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marius M Hoeper

Showing results (201-210 of 311) with videos related to

Pageof 32
Sort By:
International Journal of Cardiology|January 7, 2012
Chronic thromboembolic pulmonary hypertension (CTEPH): updated Recommendations of the Cologne Consensus Conference 2011Heinrike Wilkens, Irene Lang, Jürgen Behr, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|June 15, 2022
Lung transplant and severe coronary artery disease: results from a single-centre experienceMaximilian Franz, Thierry Siemeni, Khalil Aburahma, et al.
Intensive Care Medicine Experimental|November 24, 2021
Effects of therapeutic plasma exchange on the endothelial glycocalyx in septic shockKlaus Stahl, Uta Carola Hillebrand, Yulia Kiyan, et al.
International Journal of Molecular Sciences|February 15, 2022
Time-Dependent Molecular Motifs of Pulmonary Fibrogenesis in COVID-19Jan C Kamp, Lavinia Neubert, Maximilian Ackermann, et al.
The Lancet. Respiratory Medicine|August 17, 2019
Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b studySteven D Nathan, Jürgen Behr, Harold R Collard, et al.
Pulmonary Circulation|August 18, 2025
Predicting Response to Switching From Phosphodiesterase Type 5 Inhibitor to Riociguat in Patients With Pulmonary Arterial Hypertension: Biomarker and Responder Analysis of the RESPITE and REPLACE StudiesJames R Klinger, Hikmet Al-Hiti, Sung-A Chang, et al.
Respiratory Research|December 21, 2018
Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)Alberto M Marra, Michael Halank, Nicola Benjamin, et al.
Journal of Magnetic Resonance Imaging : JMRI|February 26, 2020
Chronic Thromboembolic Pulmonary Hypertension Perioperative Monitoring Using Phase-Resolved Functional Lung (PREFUL)-MRIGesa H Pöhler, Filip Klimes, Andreas Voskrebenzev, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 8, 2019
Reduced Right Ventricular Output Reserve in Patients With Systemic Sclerosis and Mildly Elevated Pulmonary Artery PressureChristian Nagel, Alberto M Marra, Nicola Benjamin, et al.
European Journal of Heart Failure|January 12, 2019
Selexipag treatment for pulmonary arterial hypertension associated with congenital heart disease after defect correction: insights from the randomised controlled GRIPHON studyMaurice Beghetti, Richard N Channick, Kelly M Chin, et al.
Pageof 32

Showing results (201-210 of 311) with videos related to

Sort By:
Pageof 32
International Journal of Cardiology|January 7, 2012
Chronic thromboembolic pulmonary hypertension (CTEPH): updated Recommendations of the Cologne Consensus Conference 2011Heinrike Wilkens, Irene Lang, Jürgen Behr, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|June 15, 2022
Lung transplant and severe coronary artery disease: results from a single-centre experienceMaximilian Franz, Thierry Siemeni, Khalil Aburahma, et al.
Intensive Care Medicine Experimental|November 24, 2021
Effects of therapeutic plasma exchange on the endothelial glycocalyx in septic shockKlaus Stahl, Uta Carola Hillebrand, Yulia Kiyan, et al.
International Journal of Molecular Sciences|February 15, 2022
Time-Dependent Molecular Motifs of Pulmonary Fibrogenesis in COVID-19Jan C Kamp, Lavinia Neubert, Maximilian Ackermann, et al.
The Lancet. Respiratory Medicine|August 17, 2019
Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b studySteven D Nathan, Jürgen Behr, Harold R Collard, et al.
Pulmonary Circulation|August 18, 2025
Predicting Response to Switching From Phosphodiesterase Type 5 Inhibitor to Riociguat in Patients With Pulmonary Arterial Hypertension: Biomarker and Responder Analysis of the RESPITE and REPLACE StudiesJames R Klinger, Hikmet Al-Hiti, Sung-A Chang, et al.
Respiratory Research|December 21, 2018
Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)Alberto M Marra, Michael Halank, Nicola Benjamin, et al.
Journal of Magnetic Resonance Imaging : JMRI|February 26, 2020
Chronic Thromboembolic Pulmonary Hypertension Perioperative Monitoring Using Phase-Resolved Functional Lung (PREFUL)-MRIGesa H Pöhler, Filip Klimes, Andreas Voskrebenzev, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 8, 2019
Reduced Right Ventricular Output Reserve in Patients With Systemic Sclerosis and Mildly Elevated Pulmonary Artery PressureChristian Nagel, Alberto M Marra, Nicola Benjamin, et al.
European Journal of Heart Failure|January 12, 2019
Selexipag treatment for pulmonary arterial hypertension associated with congenital heart disease after defect correction: insights from the randomised controlled GRIPHON studyMaurice Beghetti, Richard N Channick, Kelly M Chin, et al.
Pageof 32